Autoimmune gastritis is a chronic condition in which your immune system attacks the acid-producing cells in your stomach lining. Over time, this destroys the cells responsible for making stomach acid and a protein called intrinsic factor, which your body needs to absorb vitamin B12 and iron. The global prevalence is estimated at about 3.85%, making it more common than many people realize, and it often goes undiagnosed for years because early symptoms are vague or absent entirely.
How the Immune System Damages Your Stomach
Your stomach lining contains specialized cells called parietal cells, which do two critical jobs: they produce hydrochloric acid for digestion and they secrete intrinsic factor, a protein that binds to vitamin B12 so it can be absorbed in your intestines. In autoimmune gastritis, your immune system produces antibodies that target the acid pump on these parietal cells. Specific immune cells, primarily a type of white blood cell called CD4 T-cells, drive the attack. These T-cells release inflammatory signals that trigger parietal cell death.
The process feeds on itself. T-cell activity stimulates other immune cells to produce two types of antibodies: anti-parietal cell antibodies (found in 80 to 90% of patients) and anti-intrinsic factor antibodies (found in 30 to 60% of patients, but highly specific to the disease at 98.6%). As more parietal cells are destroyed, your stomach gradually loses the ability to produce acid and intrinsic factor. This is why the consequences of autoimmune gastritis unfold slowly, sometimes over a decade or more.
Symptoms: Early and Late Stages
One of the trickiest things about autoimmune gastritis is that it can be silent for years. The earliest detectable problem is usually iron deficiency, which develops long before vitamin B12 levels drop low enough to cause obvious symptoms. Iron deficiency shows up as fatigue, brittle nails, hair loss, restless legs, and slow wound healing. Many people are diagnosed with iron deficiency anemia and treated with supplements without anyone investigating why the iron isn’t being absorbed properly.
As the disease progresses and vitamin B12 stores deplete, the symptoms become more serious and varied. Gastrointestinal complaints include bloating, nausea, and a feeling of fullness after small meals, all related to the loss of stomach acid. Neurological symptoms can develop as B12 deficiency worsens: numbness and tingling in the hands and feet, weakness, difficulty with balance, and cognitive changes ranging from forgetfulness to significant mental disturbances. Glossitis, a painful swelling of the tongue, is another hallmark.
Pernicious anemia, the most well-known complication, is actually a late-stage finding. It develops when B12 deficiency becomes severe enough to impair red blood cell production, leading to abnormally large, dysfunctional red blood cells. This stage is diagnosed mainly in older adults. About 50% of people with autoimmune gastritis have some form of anemia, with iron deficiency and B12 deficiency being the most common causes.
How It Differs From H. pylori Gastritis
The other major cause of chronic stomach inflammation is infection with H. pylori bacteria, and the two conditions look different under a microscope. In H. pylori gastritis, the bacteria colonize the surface of the stomach lining, triggering inflammation in the upper layers and eventually causing a type of tissue change called intestinal metaplasia, where stomach tissue starts to resemble intestinal tissue. This happens in both the surface and deeper gland layers.
Autoimmune gastritis behaves differently. The inflammation concentrates deeper in the stomach wall, in the base of the glands where parietal cells live, while the surface layer stays relatively spared. In early stages, the glandular tissue undergoes a different type of change, transforming to resemble the tissue found in the lower part of the stomach or the pancreas. True intestinal metaplasia typically doesn’t appear until advanced stages of the disease. This distinction matters because it helps pathologists tell the two conditions apart on biopsy, though both can coexist in the same patient.
Linked Autoimmune Conditions
Autoimmune gastritis rarely travels alone. In a study of 320 patients, over 53% had at least one other autoimmune disorder. The most common companion is Hashimoto’s thyroiditis, an autoimmune condition affecting the thyroid gland, found in about 36% of autoimmune gastritis patients. The relationship runs both ways: roughly 10 to 40% of people with Hashimoto’s thyroiditis also have gastric disorders.
Type 1 diabetes is another significant overlap. People with type 1 diabetes are three to five times more likely to develop autoimmune gastritis than the general population, with prevalence reaching 5 to 10% in that group. If you already have one autoimmune condition, particularly thyroid disease or type 1 diabetes, screening for autoimmune gastritis can catch the disease before nutrient deficiencies cause lasting damage.
How It’s Diagnosed
Diagnosis typically involves a combination of blood tests and endoscopy with biopsy. On the blood test side, three markers are particularly useful. Pepsinogen I (a protein produced by the same cells being destroyed) drops below 30 micrograms per liter. The ratio of pepsinogen I to pepsinogen II falls below three. And gastrin-17, a hormone that rises when the stomach can’t produce enough acid, climbs above 30 picomoles per liter. Together, these markers can reliably identify patients with significant stomach lining damage even before symptoms appear.
Anti-parietal cell antibodies are highly sensitive (present in 80 to 90% of cases), making them a good screening tool. Anti-intrinsic factor antibodies are less commonly positive (30 to 60% of patients) but are extremely specific to the disease, meaning a positive result is a strong signal. Endoscopy with biopsy remains the gold standard for confirming the diagnosis, showing the characteristic pattern of gland destruction and deep inflammation in the body of the stomach.
Cancer and Tumor Risk
The chronic inflammation and tissue changes in autoimmune gastritis carry a real, though modest, increased risk of two types of stomach growths. Gastric cancer develops at a rate of about 0.14% per person per year in people with the condition. Type 1 gastric neuroendocrine tumors, small growths that develop in response to chronically elevated gastrin levels, occur at a higher rate of about 0.83% per person per year.
These numbers are low enough that the condition is not considered a high-risk cancer syndrome, but high enough that periodic surveillance with endoscopy is recommended. Current guidance focuses primarily on watching for neuroendocrine tumors, though specific schedules for how often to repeat endoscopy are still being refined. Most gastroenterologists will discuss an individualized monitoring plan based on the degree of tissue changes found on your initial biopsies.
Treatment and Long-Term Management
There is currently no treatment that stops the autoimmune attack itself. Management focuses on replacing what the damaged stomach can no longer help your body absorb. For vitamin B12, guidelines from NICE recommend lifelong replacement therapy. Intramuscular B12 injections are the standard approach because autoimmune gastritis impairs the normal absorption pathway through the gut. For people whose deficiency is caused by malabsorption, oral B12 at a dose of at least 1 mg daily is an alternative, though injections bypass the absorption problem entirely.
Iron supplementation is often needed as well, and some patients require intravenous iron if oral supplements aren’t absorbed effectively enough. Monitoring B12, iron, and ferritin levels over time helps guide how much supplementation you need. Because the disease progresses gradually, your requirements may change.
Living with autoimmune gastritis means staying on top of regular blood work to catch nutrient deficiencies before they cause symptoms, periodic endoscopies to monitor for tissue changes, and awareness that neurological symptoms like tingling or balance problems warrant prompt attention. With consistent monitoring and supplementation, most people with autoimmune gastritis manage the condition well and avoid the serious complications that come from undetected deficiencies.